LCID
Lucid Group, Inc.
LCID has the edge over MHO overall, supported by stronger valuation and stronger modeled upside.
MHO
M/I Homes, Inc.
MHO trails on the overall score without a compensating advantage in the available component scores.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
MHO Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Under pressure | |
| Strong |
MHO's balance sheet is currently strong, and its revenue and profitability are stable, but its cash flow is under pressure.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
MHO PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 3.7x | $38.94 | -69% |
| Fair | 6.6x | $69.33 | -45% |
| Expensive | 8.6x | $90.94 | -28% |
| Current | 12x | $127 | — |
| Forward | 12x | $127 | — |
Historical ranges are pointers, not guarantees.
MHO's PE is in its expensive range at 12.0x. Analysts expect earnings to fall, which would put today's price at 12.4x next year's earnings.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
MHO Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Strong decline | |
| Stable | |
| Strongly weakening | |
| Limited | |
| Moderate |
Analysts expect MHO's earnings and profitability to decline, with its revenue holding steady.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
MHO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $10.19 | -3.4% |
| Q3 2026 | $10.55 | -38% |
| Q2 2026 | $11.91 | -35% |
| Q1 2026 | $13.31 | -30% |
| Q4 2025 | $14.74 | -25% |
| Q3 2025 | $17.03 | -8.6% |
| Q2 2025 | $18.21 | -0.8% |
| Q1 2025 | $18.91 | +9% |
| Q4 2024 | $19.71 | +22% |
MHO has the edge over LCID on earnings quality, reporting a profit while its opponent remains loss making.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over MHO on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
MHO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.1B | -4.9% |
| Q2 2026 | $1.1B | -8.5% |
| Q1 2026 | $920.7M | -5.7% |
| Q4 2025 | $1.1B | -4.8% |
| Q3 2025 | $1.1B | -1% |
| Q2 2025 | $1.2B | +4.8% |
| Q1 2025 | $976.1M | -6.7% |
| Q4 2024 | $1.2B | +24% |
MHO's revenue is shrinking: $1.1B last quarter, down 4.9% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 7.7% | -4.2 points |
| Q2 2026 | 9.5% | -3.9 points |
| Q1 2026 | 9.3% | -5.1 points |
| Q4 2025 | 6.5% | -7.1 points |
| Q3 2025 | 12% | -4 points |
| Q2 2025 | 13% | -3.4 points |
| Q1 2025 | 14% | -2.1 points |
| Q4 2024 | 14% | +0.3 points |
MHO has the edge over LCID on profitability, with a higher operating margin.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
MHO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$17M | -140% |
| Q2 2026 | $31.4M | -11% |
| Q1 2026 | $135.6M | +113% |
| Q4 2025 | -$13M | -113% |
| Q3 2025 | $42M | +$110.5M |
| Q2 2025 | $35.1M | +60% |
| Q1 2025 | $63.5M | -45% |
| Q4 2024 | $102.3M | +90% |
MHO has the edge over LCID on cash generation, producing positive trailing cash flow while its opponent burns cash.
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has 395M diluted shares, up 26% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
MHO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.9% | -244K shares |
| 1 year | -4.6% | -1.2M shares |
| 3 years | -10% | -2.9M shares |
| 5 years | -14% | -4.1M shares |
| Available history | -11% | -3.1M shares |
MHO has the edge over LCID on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $50.1M |
| Q2 2026 | $50.1M |
| Q1 2026 | $50.1M |
| Q4 2025 | $51.7M |
| Q3 2025 | $50.2M |
| Q2 2025 | $50.1M |
| Q1 2025 | $50.1M |
| Q4 2024 | $51.1M |
MHO spent $202M buying back its own shares over the past year, about the same as the year before.
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
MHO Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.7x | Net Cash |
| Q2 2026 | -1.8x | Net Cash |
| Q1 2026 | -1.6x | Net Cash |
| Q4 2025 | -1.3x | Net Cash |
| Q3 2025 | -1.2x | Net Cash |
| Q2 2025 | -1.2x | Net Cash |
| Q1 2025 | -1.1x | Net Cash |
| Q4 2024 | -1.1x | Net Cash |
MHO has more cash than debt.
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
MHO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.3 | Neutral |
| Stochastic | 35.3 | Neutral |
MHO's weekly RSI is 40 (neutral) and its Stochastic is 35 (neutral).
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
MHO PE vs Consumer Cyclical Sector
| Metric | MHO | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 18x | 33% below |
| PE % | 98 | 47 | 51 pts above |
MHO is trading at 12x earnings, a 33% discount to the Consumer Cyclical sector's median of 18x.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
MHO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $129.5 | 2.2% below |
| 20 week MA | $141.0 | 10% below |
| 50 week MA | $136.8 | 7.4% below |
| 100 week MA | $130.7 | 3.1% below |
| 200 week MA | $121.0 | 4.7% above |
MHO has the edge over LCID on trend strength, trading above more of its moving averages.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.
MHO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $39.8 | $47.8 | +20% |
| 2021 | $47.8 | $60.8 | +27% |
| 2022 | $60.8 | $46.9 | -23% |
| 2023 | $46.9 | $137.7 | +194% |
| 2024 | $137.7 | $134.0 | -2.7% |
| 2025 | $134.0 | $129.0 | -3.7% |
| 2026 YTD | $129.0 | $126.7 | -1.8% |
MHO has the edge over LCID on returns for 2026, with the stronger performance.